132 related articles for article (PubMed ID: 16497500)
1. N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.
Boot JR; Boulet SL; Clark BP; Cases-Thomas MJ; Delhaye L; Diker K; Fairhurst J; Findlay J; Gallagher PT; Gilmore J; Harris JR; Masters JJ; Mitchell SN; Naik M; Simmonds RG; Smith SM; Richards SJ; Timms GH; Whatton MA; Wolfe CN; Wood VA
Bioorg Med Chem Lett; 2006 May; 16(10):2714-8. PubMed ID: 16497500
[TBL] [Abstract][Full Text] [Related]
2. Discovery and structure-activity relationships of novel selective norepinephrine and dual serotonin/norepinephrine reuptake inhibitors.
Boot J; Cases M; Clark BP; Findlay J; Gallagher PT; Hayhurst L; Man T; Montalbetti C; Rathmell RE; Rudyk H; Walter MW; Whatton M; Wood V
Bioorg Med Chem Lett; 2005 Feb; 15(3):699-703. PubMed ID: 15664840
[TBL] [Abstract][Full Text] [Related]
3. Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.
Bymaster FP; Beedle EE; Findlay J; Gallagher PT; Krushinski JH; Mitchell S; Robertson DW; Thompson DC; Wallace L; Wong DT
Bioorg Med Chem Lett; 2003 Dec; 13(24):4477-80. PubMed ID: 14643350
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, molecular docking and binding studies of selective serotonin transporter inhibitors.
Nencetti S; Mazzoni MR; Ortore G; Lapucci A; Giuntini J; Orlandini E; Banti I; Nuti E; Lucacchini A; Giannaccini G; Rossello A
Eur J Med Chem; 2011 Mar; 46(3):825-34. PubMed ID: 21272963
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and activity of a new class of dual acting norepinephrine and serotonin reuptake inhibitors: 3-(1H-indol-1-yl)-3-arylpropan-1-amines.
Mahaney PE; Vu AT; McComas CC; Zhang P; Nogle LM; Watts WL; Sarkahian A; Leventhal L; Sullivan NR; Uveges AJ; Trybulski EJ
Bioorg Med Chem; 2006 Dec; 14(24):8455-66. PubMed ID: 16973367
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and systematic evaluation of 4-arylpiperazine- and 4-benzylpiperidine napthyl ethers as inhibitors of monoamine neurotransmitters reuptake.
Paudel S; Min X; Acharya S; Khadka DB; Yoon G; Kim KM; Cheon SH
Bioorg Med Chem; 2018 Nov; 26(20):5538-5546. PubMed ID: 30293797
[TBL] [Abstract][Full Text] [Related]
7. Discovery of disubstituted piperidines and homopiperidines as potent dual NK1 receptor antagonists-serotonin reuptake transporter inhibitors for the treatment of depression.
Wu YJ; He H; Bertekap R; Westphal R; Lelas S; Newton A; Wallace T; Taber M; Davis C; Macor JE; Bronson J
Bioorg Med Chem; 2013 Apr; 21(8):2217-2228. PubMed ID: 23477943
[TBL] [Abstract][Full Text] [Related]
8. N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.
Jonathan Fray M; Bish G; Brown AD; Fish PV; Stobie A; Wakenhut F; Whitlock GA
Bioorg Med Chem Lett; 2006 Aug; 16(16):4345-8. PubMed ID: 16750359
[TBL] [Abstract][Full Text] [Related]
9. 4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.
Fish PV; Andrews MD; Jonathan Fray M; Stobie A; Wakenhut F; Whitlock GA
Bioorg Med Chem Lett; 2009 May; 19(10):2829-34. PubMed ID: 19359175
[TBL] [Abstract][Full Text] [Related]
10. N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.
Fish PV; Fray MJ; Stobie A; Wakenhut F; Whitlock GA
Bioorg Med Chem Lett; 2007 Apr; 17(7):2022-5. PubMed ID: 17267217
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.
Paudel S; Cao Y; Guo S; An B; Kim KM; Cheon SH
Bioorg Med Chem; 2015 Oct; 23(19):6418-26. PubMed ID: 26337019
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and 5HT modulating activity of stereoisomers of 3-phenoxymethyl-4-phenylpiperidines.
Engelstoft M; Hansen JB
Acta Chem Scand (Cph); 1996 Feb; 50(2):164-9. PubMed ID: 8819850
[TBL] [Abstract][Full Text] [Related]
13. 1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.
Whitlock GA; Blagg J; Fish PV
Bioorg Med Chem Lett; 2008 Jan; 18(2):596-9. PubMed ID: 18240382
[TBL] [Abstract][Full Text] [Related]
14. Further SAR studies of piperidine-based analogues of cocaine. 2. Potent dopamine and serotonin reuptake inhibitors.
Tamiz AP; Zhang J; Flippen-Anderson JL; Zhang M; Johnson KM; Deschaux O; Tella S; Kozikowski AP
J Med Chem; 2000 Mar; 43(6):1215-22. PubMed ID: 10737754
[TBL] [Abstract][Full Text] [Related]
15. Design and Synthesis of Arylamidine Derivatives as Serotonin/Norepinephrine Dual Reuptake Inhibitors.
Wen H; Qin W; Yang G; Guo Y
Molecules; 2019 Jan; 24(3):. PubMed ID: 30704101
[TBL] [Abstract][Full Text] [Related]
16. Benzothienyloxy phenylpropanamines, novel dual inhibitors of serotonin and norepinephrine reuptake.
Boot JR; Brace G; Delatour CL; Dezutter N; Fairhurst J; Findlay J; Gallagher PT; Hoes I; Mahadevan S; Mitchell SN; Rathmell RE; Richards SJ; Simmonds RG; Wallace L; Whatton MA
Bioorg Med Chem Lett; 2004 Nov; 14(21):5395-9. PubMed ID: 15454233
[TBL] [Abstract][Full Text] [Related]
17. 3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.
Vu AT; Cohn ST; Terefenko EA; Moore WJ; Zhang P; Mahaney PE; Trybulski EJ; Goljer I; Dooley R; Bray JA; Johnston GH; Leiter J; Deecher DC
Bioorg Med Chem Lett; 2009 May; 19(9):2464-7. PubMed ID: 19329313
[TBL] [Abstract][Full Text] [Related]
18. Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.
Whitlock GA; Fish PV; Fray MJ; Stobie A; Wakenhut F
Bioorg Med Chem Lett; 2008 May; 18(9):2896-9. PubMed ID: 18417343
[TBL] [Abstract][Full Text] [Related]
19. Syntheses and binding studies of new [(aryl)(aryloxy)methyl]piperidine derivatives and related compounds as potential antidepressant drugs with high affinity for serotonin (5-HT) and norepinephrine (NE) transporters.
Orjales A; Mosquera R; Toledo A; Pumar MC; García N; Cortizo L; Labeaga L; Innerárity A
J Med Chem; 2003 Dec; 46(25):5512-32. PubMed ID: 14640559
[TBL] [Abstract][Full Text] [Related]
20. Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 5.
Takeuchi K; Kohn TJ; Honigschmidt NA; Rocco VP; Spinazze PG; Hemrick-Luecke SK; Thompson LK; Evans DC; Rasmussen K; Koger D; Lodge D; Martin LJ; Shaw J; Threlkeld PG; Wong DT
Bioorg Med Chem Lett; 2006 May; 16(9):2347-51. PubMed ID: 16298130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
